BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Men Are Injecting Peptides to Build Muscle and Recover Faster But the Risks Are Real Characteristic eye presentation in BPC 157 treated eye 32 hours after Download Scientific Diagram Most people who talk about side effects from BPC 157 dont realize the problem isnt the peptide itself. The issue is that theyre getting unsterile, contaminated products from low quality research